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THE POLYENDOCRINE SYNDROMES 
BOY FRAME, M.D.* 
Physicians are often too content after diagnosing hyperfunction of a single 
endocrine organ. Such a diagnosis may be lacking in completeness. Evidence is 
increasing that hyperfunction of one endocrine gland may be accompanied by other 
endocrine hyperplasia and adenomas. Table I lists some of these polyendocrine 
syndromes that have received recent attention. Several are undoubtedly related, while 
others are separate and distinct entities. 
Table I 
1. Multiple endocrine adenoma-peptic ulcer complex (MEA) 
2. Zollinger-Ellison syndrome 
3. Familial hyperparathyroidism 
4. Hyperparathyroidism, hyperthyroidism and thyroid cancer 
5. Familial pheochromocytoma 
6. Cushing's disease and hyperparathyroidism 
7. Carcinoid syndrome in noncarcinoid malignancies 
8. Multiple hormone production in single nonendocrine 
malignancies 
Multiple Endocrine Adenoma-Peptic Ulcer Complex (MEA) 
During the past few years an opportunity was afforded to study a Negro family 
with multiple endocrine adenomas and a high incidence of peptic ulcer.' Since peptic 
ulcer and its complications were usually the presenting complaint and also the main 
cause of death, peptic ulcer is considered an integral part of the denomination. 
Forty-two members of a family over six generations were studied. Eleven members 
were proved to have the syndrome while five were highly suspect. The study was 
carried out with some difficulty since the family members live in widely separated 
*Fifth Medical Division. 
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areas of Detroit, Philadelphia and New York. The help of Dr. Harold Ballard of 
New York City in this study and investigation is duly appreciated. Most of the 
family was cooperative and wanted to know about any evidence of the condition. 
Some members, however, were fearful that the syndrome might be present and did 
not wish to know. The anxiety and concern in a family where such a serious 
hereditary condition exists can be understood. Al l varieties of response can be seen 
from complete denial to that of volunteering for medical research. 
In addition to the afflicted family members, 74 additional cases of MEA were 
found recorded in the hterature, making a total of 85 patients for analysis,' In 65% 
of the cases, pituitary involvement was present. Chromophobe adenoma occurred 
most commonly and usually resulted in symptoms of pituitary insufriciency. Acro-
megaly occurred in several instances in its classic form. 
In 82% of the cases reviewed, pancreatic islet cell adenomas or malignancies 
were found. These tumors ranged from a single large adenoma to multiple small 
adenomas, both alpha and beta cell type. In the beta cell tumors, features of 
hypoglycemia were usually present. Despite local or distant metastases in 21 instances, 
metastatic spread of islet-cell tumor was responsible for death in only one patient. 
Pancreatic islet cell carcinoma, when occurring with MEA, appears relatively benign 
compared to the isolated acinar or single beta cell pancreatic carcinoma. 
The parathyroid glands were involved in 88% of the cases. Fewer renal and 
skeletal complications were observed than is usual in primary hyperparathyroidism. 
The occurrence of renal lithiasis and nephrocalcinosis was 33% compared to an 
incidence of 75 to 80% in most series of patients with primary hyperparathyroidism. 
Skeletal involvement due to osteitis fibrosa is rarely seen in MEA. The incidence of 
primary chief cell hyperplasia and multiple parathyroid adenomas was also much 
higher than in primary hyperparathyroidism. 
In 38% of the cases, adrenocortical involvement was proved at either operation 
or necropsy and included general hyperplasia, nodular hyperplasia and cortical adeno-
mas. Despite this pathologic evidence of endocrine hyperplasia, there was little 
clinical or laboratory evidence of adrenocortical hyperfunction except in one patient 
who had simultaneous aldosteronism and hyperparathyroidism. 
The thyroid gland was involved in 19% of the cases, a higher incidence than 
previously reported. Two patients showed symptoms and signs of thyrotoxicosis, and 
one patient had a thyroid carcinoma. The remainder had one or more nonfunctioning 
thyroid adenomas. 
Peptic ulcer occurred in 49 of the 85 patients studied. More than half the ulcers 
were multifocal in origin and often atypical in location. In the majority one or more 
complications of ulcer such as hemorrhage, obstruction and perforation had occurred. 
In 15 cases, gastric hypersecretion or gastric rugar hypertrophy could be demonstrated. 
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Of theoretic interest is the relationship of the endocrine involvement to the ulcer 
diathesis. Current evidence suggests that the gastrin-like material which has been 
isolated from the pancreatic, non-beta cell tumors in a number of instances in MEA 
is the most likely cause for the gastric hypersecretion and the peptic ulcer diathesis. 
There is no substantial evidence of gastric hypersecretion occurring in hyperfunctioning 
parathyroid states. I f hyperparathyroidism does increase the incidence of peptic ulcer 
disease, it perhaps does so by altering the gastric mucosal barrier, although proof 
is lacking. Parathyroid hormone has been shown to depolymerize the mucopoly-
saccharides in gastric mucin as well as in connective tissue throughout the body. 
Serious diarrhea occurred in 11 of the 85 patients with MEA. Typically, the 
stools in these patients were loose and watery and often were associated with evidence 
of electrolyte depletion. In several instances, frank steatorrhea proved to be present. 
The mechanisms of the diarrhea may be explained in several ways. The gastric 
hyperacidity probably inactivates pancreatic lipase in the duodenal lumen and thereby 
interferes with proper digestion of fats. Not all patients with diarrhea have had 
gastric hypersecretion, however, and in at least one instance diarrhea has been relieved 
by removal of a pancreatic islet cell tumor. Also, extracts of pancreatic islet cell 
tumors in such patients have been shown to contain a substance which promotes bowel 
activity in isolated guinea pig ileum. Since both intestinal and bronchial carcinoid 
tumors may occur in MEA, and since the histology of islet cell tumors and carcinoid 
tumors may be difficult to differentiate, it is possible that serotonin may be present 
in sufficient amounts in some cases of MEA to promote peristaltic activity. Recent 
work from this hospital has demonstrated elevated blood serotonin and histamine 
levels in patients with Zollinger-Ellison and MEA syndromes, but diarrhea in these 
patients was thought not due to the increased levels of serotonin.^ Other patients in 
the future, however, may demonstrate such a relationship. 
For some strange and unexplained reason, there seems to be an increased incidence 
of lipomas in MEA. Eleven patients in the current review had lipomas, often multi-
centric and found in unusual locations such as the lung and retroperitoneal space. 
It is of interest that a multiendocrine syndrome has been reported to occur 
spontaneously in animals. Also, after exposure to large doses of Xrays, rats of 
various ages may develop numerous multiendocrine tumors. The basic defect causing 
adenomatosis of the endocrine glands is not known, but the high familial incidence 
suggests a mutant gene that is readily transmittable. Hereditary studies available 
at present indicate that transmission is along the lines of autosomal dominance with 
a high degree of penetrance. Chromosomal studies performed on several members of 
the family reported revealed normal karyotypes. 
ZOLLINGER-ELLISON SYNDROME 
It has been ten years since the Zollinger-Ellison syndrome was first described.''' 
By definition this syndrome is characterized by gastric hyperacidity, severe peptic 
ulceration with or without diarrhea and one or more non-beta islet cell tumors of the 
pancreas. Long-term study of these patients indicates that many have underlying 
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multiple endocrine gland involvement. Both MEA and the Zollinger-Ellison syndrome 
undoubtedly have a common genetic background. With present information, it is 
reasonable to assume that the Zollinger-Ellison syndrome is a special variant of the 
more inclusive MEA-peptic ulcer complex. The Zollinger-Ellison tumor represents 
the gastrin-secreting islet-cell tumor in MEA and very likely accounts for the high 
incidence of peptic ulcer disease. 
FAMILIAL HYPERPARATHYROIDISM 
Several families have been reported with a high incidence of peptic ulcer, kidney 
stones or pancreatitis in which underlying primary hyperparathyroidism has been 
present.'"' The histology of the parathyroid glands in these families has varied. Where 
the parathyroids have demonstrated primary chief cell hyperplasia, the probability 
of associated polyendocrine involvement increased.' Endocrine tumors often remain 
dormant for many years and it is only by following patients through to operation or 
necropsy that a final opinion regarding the association of multiple endocrine lesions 
can be given. 
HYPERPARATHYROIDISM, HYPERTHYROIDISM AND THYROID CANCER 
Several instances of simultaneous hyperthyroidism and hyperparathyroidism are 
recorded.''" Since both conditions may give rise to hypercalcemia, a problem in 
differential diagnosis can occur. Most recordings of this combined endocrine hyper-
function have included no evidence of other endocrine involvement. It is not known 
whether these examples of polyendocrine disease have occurred by chance or 
are in some way related. Experimental evidence shows that a calcium-rich diet in 
animals results in increased incidence of thyroid hyperplasia and adenomatous forma-
tion." Hellstrom records an increased number of adenomas and nodular changes in 
the thyroid gland in patients with primary hyperparathyroidism.'^ Perhaps in some 
instances such adenomatous changes progress to carcinoma. To support this concept, 
Ehlenberg and associates reported an unexpectedly high incidence of thyroid carcinoma 
in patients operated on for parathyroid adenoma.'^  In a series of 93 patients with 
primary hyperparathyroidism, 7 patients (or 7.5%) were found at operation to have 
associated thyroid carcinoma. This experience suggests that surgeons operating on 
patients for parathyroid adenoma should carefully explore the thyroid glands in an 
attempt to detect areas of early malignancy. 
FAMILIAL PHEOCHROMOCYTOMA 
Approximately 20 families have been reported with familial pheochromocytoma, 
and in several of these families thyroid carcinoma and even parathyroid adenomas 
have been found.'" Pheochromocytomas in these instances are frequently bilateral. 
This entity is inherited as an autosomal dominant gene with a high penetrance similar 
to that seen in MEA. Again the question arises as to whether we are dealing with 
a separate polyendocrine syndrome or a variation of the multiple endocrine-peptic 
ulcer complex. The fact that patients with familial pheochromocytoma have not had 




PRIMARY HYPERPARATHYROIDISM AND CUSHING'S SYNDROME 
Raker and associates have documented two patients with simultaneous occurrence 
of primary hyperparathyroidism and Cushing's syndrome.'= Neither had a family 
history to suggest hereditary tendency, peptic ulcer disease or other endocrine disorder. 
Both hyperparathyroidism and Cushing's disease may cause bone disease, nephro-
calcinosis and renal stones. There is little supporting evidence that hyperfunction of 
the adrenal cortex can produce an elevation of the serum calcium; in fact, adrenocortical 
hypofunction is more likely to be associated with hypercalcemia. Of special interest 
is the 15-year-old girl who had biochemical evidence of simultaneous hyperparathy-
roidism and aldosteronism.' This is thought to be the only report of this endocrine 
combination. 
CARCINOID SYNDROME I N NONCARCINOID MALIGNANCIES 
Intestinal and bronchial carcinoids, as mentioned previously, have been described 
in association with the multiple endocrine adenoma-peptic ulcer complex.' Recent 
evidence suggests that noncarcinoid tumors found in such organs as the pancreas, 
lung and thyroid may be associated with the characteristic clinical and laboratory 
features of the carcinoid syndrome." Of importance to the current discussion of 
polyendocrine disease is the fact that 3 of 8 patients so described have had evidence 
of other endocrine hyperfunction. In one patient, simultaneous Cushing's syndrome 
was present, in another, hyperinsulinism and in a third, hyperparathyroidism. The 
entire area of carcinoid syndrome and associated multiple endocrine hyperfunction 
needs further investigation. 
M U L T I P L E HORMONE PRODUCTION I N SINGLE NONENDOCRINE MALIGNANCIES 
In recent years there have been numerous reports that malignant tumors from a 
variety of nonendocrine sources may produce hormone-like substances such as insulin, 
gastrin, parathyroid hormone, antidiuretic hormone, ACTH, TSH and chorionic 
gonadotropin. In several cases, two separate hormone-like materials have been isolated 
from a single tumor. Recently a patient with a malignant islet cell tumor of the pancreas 
that produced three separate substances similar to ACTH, melanocyte-stimulating 
hormone and gastrin, was reported." This illustrates another form of polyendocrine 
disease where multiple hormones are synthesized and released from the cells of a 
single malignant tumor. Other examples of this unusual polyhormonal syndrome will 
undoubtedly be uncovered. The ability of a cancerous cell to produce a variety of 
hormonal substances is intriguing and may hold a clue to the nature and control of 
certain malignancies. 
Delineation of the various polyendocrine syndromes is in its infancy. Exciting 
advances in this area are awaited as assay methods for various hormones improve. 
The number of possible combinations occurring as the result of hyperplasia and 
adenomas in the endocrine glands, as well as those arising in malignant tumors of 
nonendocrine tissue, staggers the imagination. I t is again emphasized that the physician 
should not be content with diagnosis of hyperfunction in a single endocrine gland, 
but should be continually on the alert for evidence of polyendocrine involvement. 
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